BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9099195)

  • 1. We need stronger predictors of major vascular events in patients with a recent transient ischemic attack or nondisabling stroke. Dutch TIA Trial Study Group.
    Dippel DW; Koudstaal PJ
    Stroke; 1997 Apr; 28(4):774-6. PubMed ID: 9099195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.
    Stroke; 1993 Apr; 24(4):543-8. PubMed ID: 8465360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. The Dutch TIA Trial Study Group.
    Stroke; 1993 Apr; 24(4):527-31. PubMed ID: 8465356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group.
    Koudstaal PJ; Algra A; Pop GA; Kappelle LJ; van Latum JC; van Gijn J
    Lancet; 1992 Sep; 340(8820):630-3. PubMed ID: 1355211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke. The Dutch TIA Study Group.
    Stroke; 1988 Apr; 19(4):512-7. PubMed ID: 2896402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.
    ; van Gijn J; Algra A; Kappelle J; Koudstaal PJ; van Latum A
    N Engl J Med; 1991 Oct; 325(18):1261-6. PubMed ID: 1922220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of major vascular events in patients with transient ischemic attack or ischemic stroke: a comparison of 7 models.
    Wijnhoud AD; Maasland L; Lingsma HF; Steyerberg EW; Koudstaal PJ; Dippel DW
    Stroke; 2010 Oct; 41(10):2178-85. PubMed ID: 20814011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.
    Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.
    Clark TG; Murphy MF; Rothwell PM
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):577-80. PubMed ID: 12700296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS).
    O'Connor CM; Gattis WA; Hellkamp AS; Langer A; Larsen RL; Harrington RA; Berkowitz SD; O'Gara PT; Kopecky SL; Gheorghiade M; Daly R; Califf RM; Fuster V
    Am J Cardiol; 2001 Sep; 88(5):541-6. PubMed ID: 11524065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.
    Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Held P; Jonasson J; Minematsu K; Molina CA; Wong LK
    Int J Stroke; 2015 Dec; 10(8):1304-8. PubMed ID: 26311628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial.
    Li J; Zhao X; Meng X; Lin J; Liu L; Wang C; Wang A; Wang Y; Wang Y;
    Stroke; 2016 Aug; 47(8):2025-30. PubMed ID: 27328699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiography in patients with symptomatic intracranial stenosis.
    Kasner SE; Lynn MJ; Jackson BP; Pullicino PM; Chimowitz MI;
    J Stroke Cerebrovasc Dis; 2007; 16(5):216-9. PubMed ID: 17845919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
    Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
    Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.